Jakob Passweg

1996–2025 年に発表

250
論文数
34,115
被引用数
101
h 指数
235
i10 指数

被引用数

Jakob Passweg の年別被引用数1983 年: 被引用 5 件1985 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 15 件1999 年: 被引用 30 件2000 年: 被引用 56 件2001 年: 被引用 45 件2002 年: 被引用 76 件2003 年: 被引用 91 件2004 年: 被引用 63 件2005 年: 被引用 126 件2006 年: 被引用 169 件2007 年: 被引用 190 件2008 年: 被引用 174 件2009 年: 被引用 200 件2010 年: 被引用 168 件2011 年: 被引用 209 件2012 年: 被引用 207 件2013 年: 被引用 194 件2014 年: 被引用 206 件2015 年: 被引用 278 件2016 年: 被引用 184 件2017 年: 被引用 248 件2018 年: 被引用 201 件2019 年: 被引用 929 件2020 年: 被引用 949 件2021 年: 被引用 863 件2022 年: 被引用 753 件2023 年: 被引用 493 件2024 年: 被引用 1,051 件2025 年: 被引用 355 件2026 年: 被引用 5 件1984 年は被引用が無いため表示していません1986〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,795 件、この内訳の 21.6%ドイツ: 引用元論文 1,078 件、この内訳の 8.3%イタリア: 引用元論文 925 件、この内訳の 7.1%イギリス: 引用元論文 884 件、この内訳の 6.8%フランス: 引用元論文 868 件、この内訳の 6.7%中国: 引用元論文 605 件、この内訳の 4.7%スイス: 引用元論文 547 件、この内訳の 4.2%オランダ: 引用元論文 512 件、この内訳の 3.9%スペイン: 引用元論文 502 件、この内訳の 3.9%カナダ: 引用元論文 312 件、この内訳の 2.4%オーストラリア: 引用元論文 280 件、この内訳の 2.2%日本: 引用元論文 280 件、この内訳の 2.2%
0%21.6%その他 26%

分野

  • Medicine83.7%
  • Immunology and Microbiology9.3%
  • Biochemistry, Genetics and Molecular Biology5.5%
  • Engineering0.2%
  • Neuroscience0.2%
  • Agricultural and Biological Sciences0.1%
  • その他1%

トピック

  • Hematopoietic Stem Cell Transplantation11.9%
  • Acute Myeloid Leukemia Research9%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment6.1%
  • Immune Cell Function and Interaction4.2%
  • Acute Lymphoblastic Leukemia research3.4%
  • Chronic Myeloid Leukemia Treatments3.1%
  • その他62.3%

共著者

全論文

検索で開く
  1. A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

    著者: , , , , , , , , - New England Journal of Medicine 2005 被引用: 3,459

  2. Molecular Minimal Residual Disease in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 781

  3. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2019 被引用: 393

  4. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2020 被引用: 538

  5. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

    著者: , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2021 被引用: 428

  6. Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabina De Geest, Olivier de Rougemont, Michael Dickenmann, Michel Duchosal, Laure Elkrief, Thomas Fehr, Sylvie Ferrari‐Lacraz, Christian Garzoni, Paola Gasche Soccal, Christophe Gaudet, Emiliano Giostra, Déla Golshayan, Karine Hadaya, Jörg Halter, D. Hauri, Dominik Heim, Christoph Hess, Sven Hillinger, Hans H. Hirsch, Günther Hofbauer, Uyen Huynh-Do, Franz Immer, Richard Klaghofer, Michael Koller, Bettina Laesser, Guido F. Laube, Roger Lehmann, Christian Lovis, Pietro Majno, Oriol Manuel, Hans‐Peter Marti, Pierre Yves Martin, Michele Martinelli, Pascal Meylan, Nicolas J Mueller, Antonia Müller, Thomas Müller, Beat Müllhaupt, Manuel Pascual, Jakob Passweg, Klara M. Posfay‐Barbe, Juliane Rick, Eddy Roosnek, Anne Rosselet, Silvia Rothlin, Frank Ruschitzka, Urs Schanz, Stefan Schaub, Aurelia Schnyder, Christian Seiler, Jan Sprachta, Susanne Stampf, Jürg Steiger, Guido Stirnimann, Christian Toso, Christian van Delden, Jean-Pierre Venetz, Jean Villard, Madeleine Wick, Markus J. Wilhelm, Patrick Yerly, Patrizia Amico, John‐David Aubert, Vanessa Banz, Guido Beldi, Christian Benden, Christoph Berger, Isabelle Binet, Pierre-Yves Bochud, Sanda Branca ほか 65 名 - Clinical Infectious Diseases 2019 被引用: 305

  7. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Serena Marotta, Talha Munir, Jennifer M.L. Tjon, Suzanne Tavitian, Aline Praire, Laurence Clément, Florence Rabian, Luana Marano, Anita Hill, Elena Palmisani, Petra Muus, Fabiana Cacace, Camilla Frieri, M. Van Lint, Jakob Passweg, Judith Marsh, Gèrard Socié, Ghulam J. Mufti, Carlo Dufour, Antonio M. Risitano - New England Journal of Medicine 2022 被引用: 298

  8. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2024 被引用: 222

  9. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2017 被引用: 376

  10. High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennita Slomp, Alexander N. Snel, Marie‐Christiane Vekemans, Bob Löwenberg, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis - Journal of Clinical Oncology 2013 被引用: 449

  11. Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie Robin, Raffaella Greco, Donal P. McLornan - Blood Advances 2024 被引用: 61

  12. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mats Brune, Alexandros Spyridonidis, A Schmitt-Gräff, Walter J. F. M. van der Velden, Gerwin Huls, Stephan Mielke, Goetz Ulrich Grigoleit, Jürgen Kuball, Ryan Flynn, Gabriele Ihorst, Jing Du, Bruce R. Blazar, R. Arnold, Nicolaus Kröger, Jakob Passweg, Jörg Halter, G. Socié, Dietrich W. Beelen, Christian Peschel, Andreas Neubauer, Jürgen Finke, Justus Duyster, Nikolas von Bubnoff - Leukemia 2015 被引用: 540

  13. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey

    著者: , , , , , , , , , , , , , , - Bone Marrow Transplantation 2023 被引用: 85

  14. One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nina Worel, Mickey B C Koh, Mahmoud Aljurf, Hildegard Greinix, Yoshiko Atsuta, Wael Saber - Haematologica 2021 被引用: 237

  15. Dasatinib for treatment of CAR T-cell therapy-related complications

    著者: , , , , , , , , - Journal for ImmunoTherapy of Cancer 2022 被引用: 46

  16. Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

    著者: , , , , , , , , , , , , , , , - Blood 2019 被引用: 175

  17. Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant Recipients

    著者: , , , , , , - New England Journal of Medicine 2002 被引用: 1,214

  18. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2011 被引用: 322

  19. Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie-Cecile J. C. Legdeur, Thomas Fischer, Juergen Kuball, Jan J. Cornelissen, Kimmo Porkka, Gunnar Juliusson, Peter Meyer, Martin Höglund, Bjørn Tore Gjertsen, Jeroen J. W. M. Janssen, Gerwin Huls, Jakob Passweg, Jacqueline Cloos, Peter J.M. Valk, Catharina Van Elssen, Markus G. Manz, Yngvar Fløisand, Gert J. Ossenkoppele - Blood Advances 2021 被引用: 66

  20. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

    著者: , , , , , , , , , , , , - Blood 2014 被引用: 641

  21. IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

    著者: , , , , , , , , , , , , , - British Journal of Haematology 1997 被引用: 691

  22. Solid Cancers after Bone Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 1997 被引用: 968

  23. Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 被引用: 126

  24. Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey

    著者: , , , , , , , , , , , , , , , , - Bone Marrow Transplantation 2022 被引用: 72